CRISPR/Cas13-mediated Dynamin 2 reduction therapy in a canine model of <i>DNM2</i> -related centronuclear myopathy
Andrea Carlier(Inserm), Isabel Punzón(Inserm)
Cited by 0
Related Papers
Thyroid Hormone Signaling in the Xenopus laevis Embryo Is Functional and Susceptible to Endocrine Disruption
|Endocrinology|2012|88
In vivo stem cell tracking using scintigraphy in a canine model of DMD
|Scientific Reports|2020|39
Towards a humanized PPARγ reporter system for in vivo screening of obesogens
|Molecular and Cellular Endocrinology|2013|16
In Vivo Myoblasts Tracking Using the Sodium Iodide Symporter Gene Expression in Dogs
|Molecular Therapy — Methods & Clinical Development|2020|7